Pharmaceuticals News and Research

RSS

University of Leicester launches one-year Masters degree in Cancer Chemistry

The degree is the first of its kind in the country, fulfilling a need to provide graduates with skills in the chemistry and biology of cancer, and direct experience of some of the very latest research in the field.

22 May 2007

Weill Cornell Medical College students help change global health policy

In a move to improve global public health, Weill Cornell Medical College students have helped place a lifesaving heart disease drug onto the World Health Organization's (WHO) list of essential medicines.

22 May 2007

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome

A new study demonstrated that the active ingredient in AMITIZA (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable bowel syndrome with constipation (IBS-C).

22 May 2007

Caspase-14 protein protects skin against UVB and dehydration

Ultraviolet rays can be harmful to our skin and pave the way to the onset of skin cancers.

22 May 2007

When is an herbal tea a safe and effective sleep aid?

When is an herbal tea a safe and effective sleep aid, and when is that same tea a risky pharmaceutical choice?

18 May 2007

Ulcerative colitis disruptive in relationships

Nearly three out of four ulcerative colitis (UC) sufferers (73 percent) responding to a new nationwide survey say not feeling well has become a normal part of life.

18 May 2007

Ranbaxy receives tentative FDA approval for Fexofenadine hydrochloride tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market the antihistamine Fexofenadine Hydrochloride Tablets, 30 mg, 60 mg, and 180 mg.

18 May 2007

Peregrine Pharmaceuticals to initiate new Bavituximab HCV trial

Peregrine Pharmaceuticals has announced it has filed a new clinical trial protocol with the FDA to study bavituximab in patients co-infected with HCV and the human immunodeficiency virus (HIV).

18 May 2007

Danube Pharmaceuticals starts trial of DNB-001 in patients with ocular hypertension

Danube Pharmaceuticals, Inc. has announced the initiation of a multi-center, randomized, double-blind, placebo controlled Phase II study with DNB-001 in 60 patients with ocular hypertension (elevated intraocular pressure).

18 May 2007

AMDL receives Israeli patent for animal model for the evaluation of vaccines

AMDL, Inc. has announced that it has received an important Israeli patent for an animal model for the evaluation of vaccines, which is a part of its unique Combination Immune Therapy (CIT) technology.

18 May 2007

Innovative drug-delivery system for rotavirus vaccine

A thin strip that dissolves in the mouth like a popular breath-freshener could someday provide life-saving rotavirus vaccine to infants in impoverished areas.

17 May 2007

Innovation in child-allergy detection

In the past decade, food allergies have become a major point of concern for paediatricians, especially those treating very young children.

16 May 2007

Smokeless cannabis-vaporizing device may help those with HIV-related neuropathy

A smokeless cannabis-vaporizing device delivers the same level of active therapeutic chemical and produces the same biological effect as smoking cannabis, but without the harmful toxins, according to UCSF researchers.

16 May 2007

Cronic obstructive pulmonary disease is a major and increasing global health epidemic

Cronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world's leading experts on lung disease.

16 May 2007

Lupin Pharmaceuticals receives FDA approval for Simvastatin tablets

Lupin Pharmaceuticals, Inc. has announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.

16 May 2007

Engineered minichromosomes for medically useful proteins and metabolites

A team of scientists at the University of Missouri-Columbia has discovered a way to create engineered minichromosomes in maize and attach genes to those minichromosomes.

16 May 2007

Inherited variations in certain genes linked to toxicity of leukemia therapy

Investigators at St. Jude Children's Research Hospital have discovered inherited variations in certain genes that make children with acute lymphoblastic leukemia (ALL) susceptible to the toxic side effects caused by chemotherapy medications.

15 May 2007

Epidemiology of obesity, pathophysiology, associated disease and management

Due to the gastrointestinal tract's role in body weight regulation, gastroenterologists should work closely with other medical disciplines to oversee and coordinate the care of obese individuals, according to an American Gastroenterological Association (AGA) Institute Obesity Task Force Report.

15 May 2007

Cardiotrophin 1 molecule shows potential for diagnosing hypertensive cardiopathy

Scientists from the Center for Applied Medical Research (CIMA) from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.

11 May 2007

Ritalin abuse is on the rise among teens

College is hard enough. But throw in end-of-semester exams, term papers and standardized tests, and there just aren't enough hours in the day. Enter Ritalin, the latest drug of choice among sleep-deprived students struggling to make the grade.

11 May 2007